Insulin glulisine

🧮 Dose calculator

Type 1 diabetes · Regimen source: FDA Apidra · 2.3FDA Apidra · 2

👥 Special populations

• 🤰 PregnancyUse with caution

  Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Apidra · 8.1

  “Risk Summary Available pharmacovigilance data have not established an association with insulin glulisine use during pregnancy and major birth defects, miscarriage or adverse maternal or fetal outcomes.”

• 🤱 BreastfeedingUse with caution

  Label: use with caution while breastfeeding; see the label text. FDA Apidra · 8.2

  “Risk Summary Available data from published literature suggest that human insulin products, including APIDRA, are transferred into human milk.”

• 👶 ChildrenUse with caution

  The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Apidra · 8.4

  “The safety and effectiveness of APIDRA to improve glycemic control have been established in pediatric patients.”

• 👴 Older adultsUse with caution

  Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Apidra · 8.5

  “Nevertheless, caution should be exercised when APIDRA is administered to geriatric patients.”

• ⚥ Females & males of reproductive potentialNo data

  The source for this drug has no section for this group.